Free Trial

Aileron Therapeutics (ALRN) Earnings Date, Estimates & Call Transcripts

Aileron Therapeutics logo
$4.12
+0.27 (+7.01%)
(As of 10/31/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 1Estimated
Actual EPS
(Aug. 14)
-$0.45 Missed By -$0.20
Consensus EPS
(Aug. 14)
-$0.25
Skip Charts & View Estimated and Actual Earnings Data

ALRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALRN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aileron Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20241($0.15)($0.15)($0.15)

ALRN Earnings Date and Information

Aileron Therapeutics last posted its quarterly earnings results on August 14th, 2024. The reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.20. Aileron Therapeutics has generated ($3.19) earnings per share over the last year (($3.19) diluted earnings per share). Earnings for Aileron Therapeutics are expected to grow in the coming year, from ($1.41) to ($1.40) per share. Aileron Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off prior year's report dates.

Aileron Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/1/2024
(Estimated)
------- 
8/14/2024-($0.25)($0.45)($0.20)($0.45)--  
5/20/2024-($0.14)($0.86)($0.72)($0.86)--
4/15/2024Q4 2023-($1.54)($1.54)($1.54)--  
10/13/2023Q3 2023-($0.40)($0.40)($0.40)--
8/11/2023Q2 2023-($0.39)($0.39)($0.39)--
5/8/2023Q1 2023-($0.82)($0.82)($0.59)--
11/1/2022Q3 2022($32.00)($28.00)+$4.00($1.40)--  
8/15/2022Q2 2022($1.80)($1.80)-($0.09)--  
5/5/2022Q1 2022($1.60)($1.80)($0.20)($0.09)--  
3/28/2022Q4 2021-($1.60)($1.60)($0.08)--  
11/12/2021Q3 2021($1.40)($1.40)-($0.07)--  
8/10/2021Q2 2021($1.40)($1.20)+$0.20($0.06)--  
5/10/2021Q1 2021($1.40)($1.60)($0.20)($0.08)--  
3/23/2021Q4 2020($2.60)($2.40)+$0.20($0.12)--
11/17/2020Q3 2020($2.60)($2.60)-($0.13)--
8/5/2020Q2 2020($3.80)($2.80)+$1.00($0.14)--
5/11/2020Q1 2020($4.04)($4.8904)($0.8504)($0.24)--
3/30/2020Q4 2019($5.40)($5.20)+$0.20($0.26)--
11/7/2019Q3($4.60)($5.60)($1.00)($0.28)--  

Aileron Therapeutics Earnings - Frequently Asked Questions

When is Aileron Therapeutics's earnings date?

Aileron Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off last year's report dates. Learn more on ALRN's earnings history.

Did Aileron Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Aileron Therapeutics (NASDAQ:ALRN) missed the analysts' consensus estimate of ($0.25) by $0.20 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. ALRN's actual earnings.

How much profit does Aileron Therapeutics generate each year?

Aileron Therapeutics (NASDAQ:ALRN) has a recorded net income of -$15.73 million. ALRN has generated -$3.19 earnings per share over the last four quarters.

What is Aileron Therapeutics's EPS forecast for next year?

Aileron Therapeutics's earnings are expected to grow from ($1.41) per share to ($1.40) per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:ALRN) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners